PMVP
PMV Pharmaceuticals, Inc.
+0.03 (+2.10%)1.46USD271K成交股數78.0M市值–本益比(近四季)17.4股價營收比-53.4%營收年增(近四季)2026-11-16下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | 10-29 | Mack David Henry | President and CEO | M 選擇權執行 | 221K | 1.37 | 302K | 451K | SEC |
| 2025-10-23 | 10-27 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 1.0M | 1.52 | 1.5M | 5.0M | SEC |
| 2025-10-23 | 10-27 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 1.0M | 1.52 | 1.5M | 5.0M | SEC |
| 2025-09-10 | 09-12 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 500K | 1.80 | 900K | 6.0M | SEC |
| 2025-09-10 | 09-12 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 500K | 1.80 | 900K | 6.0M | SEC |
| 2025-07-01 | 07-03 | Carulli Michael | Chief Financial Officer | S 公開市場賣出 | 28.2K | 1.06 | 30K | 60.1K | SEC |
| 2025-07-01 | 07-03 | Mack David Henry | President and CEO | S 公開市場賣出 | 58.4K | 1.06 | 62K | 536K | SEC |
| 2025-07-01 | 07-03 | Jalota Deepika | Chief Development Officer | S 公開市場賣出 | 33.1K | 1.06 | 35K | 90.0K | SEC |
| 2025-07-01 | 07-03 | Ticktin Robert | General Counsel & COO | S 公開市場賣出 | 23.2K | 1.06 | 25K | 98.7K | SEC |
| 2025-01-03 | 01-22 | Mack David Henry | President and CEO | M 選擇權執行 | 17.7K | 0.53 | 9K | 552K | SEC |
| 2024-12-03 | 01-22 | Mack David Henry | President and CEO | M 選擇權執行 | 91.8K | 0.53 | 49K | 534K | SEC |
| 2024-09-11 | 09-12 | Carulli Michael | Chief Financial Officer | S 公開市場賣出 | 2.9K | 1.50 | 4K | 88.4K | SEC |
| 2024-09-11 | 09-12 | Jalota Deepika | Chief Development Officer | S 公開市場賣出 | 7.2K | 1.50 | 11K | 118K | SEC |
| 2024-01-18 | 01-22 | Carulli Michael | Chief Financial Officer | A 獲配股票 | 82.2K | – | – | 91.3K | SEC |
| 2024-01-18 | 01-22 | Jalota Deepika | Chief Development Officer | A 獲配股票 | 95.6K | – | – | 126K | SEC |
| 2024-01-18 | 01-22 | Mack David Henry | President and CEO | A 獲配股票 | 164K | – | – | 442K | SEC |
| 2023-11-22 | 11-24 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 87.8K | 2.23 | 196K | 0 | SEC |
| 2023-11-22 | 11-24 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 87.8K | 2.23 | 196K | 0 | SEC |
| 2023-11-22 | 11-24 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 87.8K | 2.23 | 196K | 0 | SEC |
| 2023-11-10 | 11-13 | Mack David Henry | President and CEO | G 贈與 | 85.3K | – | – | 165K | SEC |
| 2023-11-10 | 11-13 | Mack David Henry | President and CEO | G 贈與 | 85.3K | – | – | 279K | SEC |
| 2023-10-18 | 11-13 | Mack David Henry | President and CEO | M 選擇權執行 | 198K | 0.53 | 105K | 364K | SEC |
| 2023-09-15 | 09-18 | Alland Leila | Chief Medical Officer | S 公開市場賣出 | 6.3K | 6.62 | 42K | 45.9K | SEC |
| 2023-09-15 | 09-18 | Jalota Deepika | Chief Development Officer | S 公開市場賣出 | 4.1K | 6.62 | 27K | 29.9K | SEC |
| 2023-08-07 | 08-08 | Mack David Henry | President and CEO | M 選擇權執行 | 85.5K | 0.53 | 45K | 165K | SEC |
| 2022-11-25 | 01-30 | Kung Winston | COO, CFO | G 贈與 | 2.6K | – | – | 10.6K | SEC |
| 2022-09-09 | 09-13 | Jalota Deepika | SVP, Regulatory Affairs and QA | A 獲配股票 | 34.0K | – | – | 34.0K | SEC |
| 2022-09-09 | 09-13 | Alland Leila | Chief Medical Officer | A 獲配股票 | 52.2K | – | – | 52.2K | SEC |
| 2022-05-26 | 05-31 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 26.3K | 15.93 | 418K | 87.8K | SEC |
| 2022-05-26 | 05-31 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 26.3K | 15.93 | 418K | 87.8K | SEC |
| 2022-05-26 | 05-31 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 26.3K | 15.93 | 418K | 87.8K | SEC |
| 2022-04-27 | 04-29 | Mack David Henry | President and CEO | M 選擇權執行 | 33.0K | 0.53 | 17K | 80.0K | SEC |
| 2022-04-20 | 04-21 | Kung Winston | COO, CFO | M 選擇權執行 | 4.0K | 3.22 | 13K | 10.6K | SEC |
| 2022-03-31 | 03-31 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 34.5K | 21.17 | 730K | 0 | SEC |
| 2022-03-31 | 03-31 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 34.5K | 21.17 | 730K | 0 | SEC |
| 2022-03-31 | 03-31 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 34.5K | 21.17 | 730K | 0 | SEC |
| 2022-03-31 | 03-31 | ORBIMED CAPITAL LLC | TenPercentOwner | S 公開市場賣出 | 34.5K | 21.17 | 730K | 0 | SEC |
| 2022-03-30 | 03-31 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 75.0K | 22.39 | 1.7M | 34.5K | SEC |
| 2022-03-30 | 03-31 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 75.0K | 22.39 | 1.7M | 34.5K | SEC |
| 2022-03-30 | 03-31 | ORBIMED CAPITAL LLC | TenPercentOwner | S 公開市場賣出 | 75.0K | 22.39 | 1.7M | 34.5K | SEC |
| 2022-03-30 | 03-31 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 75.0K | 22.39 | 1.7M | 34.5K | SEC |
| 2022-03-29 | 03-31 | OrbiMed Capital GP V LLC | TenPercentOwner | S 公開市場賣出 | 365K | 21.52 | 7.9M | 110K | SEC |
| 2022-03-29 | 03-31 | ORBIMED CAPITAL LLC | TenPercentOwner | S 公開市場賣出 | 365K | 21.52 | 7.9M | 110K | SEC |
| 2022-03-29 | 03-31 | OrbiMed Genesis GP LLC | TenPercentOwner | S 公開市場賣出 | 365K | 21.52 | 7.9M | 110K | SEC |
| 2022-03-29 | 03-31 | ORBIMED ADVISORS LLC | TenPercentOwner | S 公開市場賣出 | 365K | 21.52 | 7.9M | 110K | SEC |
| 2022-03-08 | 03-09 | Mack David Henry | President and CEO | M 選擇權執行 | 20.0K | 1.37 | 27K | 47.0K | SEC |
| 2021-12-30 | 02-08 | Kung Winston | COO, CFO | G 贈與 | 2.7K | – | – | 6.6K | SEC |
| 2021-12-15 | 12-16 | Mack David Henry | President and CEO | M 選擇權執行 | 9.0K | 0.53 | 5K | 27.0K | SEC |
| 2021-12-09 | 12-16 | Mack David Henry | President and CEO | G 贈與 | 40.0K | – | – | 188K | SEC |
| 2021-12-09 | 12-16 | Mack David Henry | President and CEO | G 贈與 | 40.0K | – | – | 40.0K | SEC |
| 2021-10-06 | 10-08 | Schroeder Thilo | Director | S 公開市場賣出 | 800 | 30.15 | 24K | 1.1M | SEC |
| 2021-10-04 | 10-04 | Schroeder Thilo | Director | S 公開市場賣出 | 100 | 30.08 | 3K | 1.1M | SEC |
| 2021-10-01 | 10-04 | Schroeder Thilo | Director | S 公開市場賣出 | 11.5K | 30.10 | 347K | 1.1M | SEC |
| 2021-09-30 | 10-04 | Schroeder Thilo | Director | S 公開市場賣出 | 3.0K | 30.03 | 89K | 1.1M | SEC |
| 2021-09-29 | 09-29 | Schroeder Thilo | Director | S 公開市場賣出 | 5.7K | 30.04 | 171K | 1.1M | SEC |
| 2021-09-27 | 09-29 | Schroeder Thilo | Director | S 公開市場賣出 | 1.8K | 30.11 | 53K | 1.1M | SEC |
| 2021-09-22 | 09-24 | Schroeder Thilo | Director | S 公開市場賣出 | 100 | 30.00 | 3K | 1.1M | SEC |
| 2021-09-22 | 09-23 | LEVINE ARNOLD J | Director | S 公開市場賣出 | 3.5K | 30.00 | 105K | 410K | SEC |
| 2021-09-17 | 09-21 | Schroeder Thilo | Director | S 公開市場賣出 | 711 | 30.03 | 21K | 1.1M | SEC |
| 2021-09-13 | 09-13 | Schroeder Thilo | Director | S 公開市場賣出 | 13.3K | 30.20 | 401K | 1.1M | SEC |
| 2021-09-10 | 09-13 | Schroeder Thilo | Director | S 公開市場賣出 | 38.1K | 30.44 | 1.2M | 1.1M | SEC |
| 2021-09-10 | 09-13 | Schroeder Thilo | Director | S 公開市場賣出 | 5.2K | 31.03 | 160K | 1.1M | SEC |
| 2021-09-09 | 09-13 | Schroeder Thilo | Director | S 公開市場賣出 | 14.3K | 30.31 | 434K | 1.2M | SEC |
| 2021-09-09 | 09-10 | Alland Leila | Chief Medical Officer | S 公開市場賣出 | 100 | 30.25 | 3K | 0 | SEC |
| 2021-09-09 | 09-10 | Alland Leila | Chief Medical Officer | M 選擇權執行 | 100 | 3.90 | 390.00 | 100 | SEC |
| 2021-09-07 | 09-08 | Alland Leila | Chief Medical Officer | S 公開市場賣出 | 3.9K | 30.25 | 118K | 0 | SEC |
| 2021-09-07 | 09-08 | Alland Leila | Chief Medical Officer | M 選擇權執行 | 3.9K | 3.90 | 15K | 3.9K | SEC |
| 2021-09-02 | 09-02 | Schroeder Thilo | Director | S 公開市場賣出 | 5.4K | 30.15 | 163K | 1.2M | SEC |
| 2021-09-01 | 09-02 | Schroeder Thilo | Director | S 公開市場賣出 | 22.0K | 30.38 | 668K | 1.2M | SEC |
| 2021-08-31 | 09-02 | Schroeder Thilo | Director | S 公開市場賣出 | 19.5K | 30.12 | 588K | 1.2M | SEC |
| 2021-08-30 | 08-30 | Schroeder Thilo | Director | S 公開市場賣出 | 13.2K | 30.05 | 398K | 1.2M | SEC |
| 2021-08-27 | 08-30 | Schroeder Thilo | Director | S 公開市場賣出 | 1.0K | 31.06 | 32K | 1.3M | SEC |
| 2021-08-27 | 08-30 | Schroeder Thilo | Director | S 公開市場賣出 | 23.4K | 30.50 | 714K | 1.3M | SEC |
| 2021-08-26 | 08-30 | Schroeder Thilo | Director | S 公開市場賣出 | 6.1K | 31.13 | 190K | 1.3M | SEC |
| 2021-08-26 | 08-30 | Schroeder Thilo | Director | S 公開市場賣出 | 15.1K | 30.39 | 458K | 1.3M | SEC |
| 2021-08-25 | 08-25 | Schroeder Thilo | Director | S 公開市場賣出 | 13.5K | 31.01 | 419K | 1.6M | SEC |
| 2021-08-24 | 08-25 | Schroeder Thilo | Director | S 公開市場賣出 | 14.5K | 31.08 | 450K | 1.6M | SEC |
| 2021-08-23 | 08-25 | Schroeder Thilo | Director | S 公開市場賣出 | 700 | 31.06 | 22K | 1.6M | SEC |
| 2021-08-23 | 08-25 | Schroeder Thilo | Director | S 公開市場賣出 | 23.1K | 30.66 | 709K | 1.6M | SEC |
| 2021-08-23 | 08-24 | LEVINE ARNOLD J | Director | S 公開市場賣出 | 3.5K | 29.50 | 103K | 413K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BML Capital Management, LLC | 5.3M | 7.1M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 4.2M | 5.7M | 新進 | 新進 |
| Sio Capital Management, LLC | 2.6M | 3.5M | 新進 | 新進 |
| Euclidean Capital LLC | 2.6M | 3.5M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.4M | 3.2M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 2.7M | 新進 | 新進 |
| ArrowMark Colorado Holdings LLC | 2.0M | 2.6M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 2.0M | 2.6M | 新進 | 新進 |
| Eversept Partners, LP | 1.9M | 2.5M | 新進 | 新進 |
| BlackRock, Inc. | 920K | 1.2M | 新進 | 新進 |
| Assenagon Asset Management S.A. | 660K | 884K | 新進 | 新進 |
| Stonepine Capital Management, LLC | 536K | 718K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 473K | 635K | 新進 | 新進 |
| Aldebaran Capital, LLC | 467K | 626K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 429K | 575K | 新進 | 新進 |
| BIT Capital GmbH | 408K | 546K | 新進 | 新進 |
| Verdad Advisers, LP | 362K | 486K | 新進 | 新進 |
| Walleye Capital LLC | 336K | 450K | 新進 | 新進 |
| MARSHALL WACE, LLP | 322K | 431K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 255K | 341K | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 240K | 322K | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 201K | 269K | 新進 | 新進 |
| STATE STREET CORP | 183K | 245K | 新進 | 新進 |
| RBF Capital, LLC | 162K | 217K | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 137K | 184K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 64 -5 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 64 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 34.6M · 64.7% |
| 合計季末市值 | 43.3M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.3M |
|---|---|
| 與上期比 | +1.0% |
| 佔流通股數 | 4.24% |
| 日均成交量 | 268K |
| 回補天數 | 8.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.3M | +1.0% | 4.24% | 268K | 8.5 |
| 2026-08-14 | 2.2M | -5.6% | 4.20% | 379K | 5.9 |
| 2026-07-31 | 2.4M | -1.8% | 4.45% | 223K | 10.7 |
| 2026-07-15 | 2.4M | -16.9% | 4.53% | 387K | 6.3 |
| 2026-06-30 | 2.9M | +1.4% | 5.44% | 351K | 8.3 |
| 2026-06-15 | 2.9M | -11.9% | 5.37% | 255K | 11.3 |
| 2026-05-29 | 3.3M | +5.6% | 6.09% | 311K | 10.5 |
| 2026-05-15 | 3.1M | +17.1% | 5.77% | 488K | 6.3 |
| 2026-04-30 | 2.6M | +13.8% | 4.93% | 347K | 7.6 |
| 2026-04-15 | 2.3M | +48.3% | 4.33% | 467K | 5.0 |
| 2026-03-31 | 1.6M | +5.1% | 2.92% | 392K | 4.0 |
| 2026-03-13 | 1.5M | +20.5% | 2.78% | 1.5M | 1.0 |
| 2026-02-27 | 1.2M | -18.0% | 2.31% | 882K | 1.4 |
| 2026-02-13 | 1.5M | -18.8% | 2.81% | 265K | 5.7 |
| 2026-01-30 | 1.9M | +3.1% | 3.46% | 333K | 5.6 |
| 2026-01-15 | 1.8M | +11.5% | 3.36% | 215K | 8.4 |
| 2025-12-31 | 1.6M | +2.3% | 3.01% | 226K | 7.1 |
| 2025-12-15 | 1.6M | +16.7% | 2.94% | 307K | 5.1 |
| 2025-11-28 | 1.3M | -12.2% | 2.52% | 235K | 5.7 |
| 2025-11-14 | 1.5M | +0.8% | 2.87% | 260K | 5.9 |
| 2025-10-31 | 1.5M | -0.2% | 2.85% | 811K | 1.9 |
| 2025-10-15 | 1.5M | +103.1% | 2.86% | 582K | 2.6 |
| 2025-09-30 | 752K | -1.2% | 1.41% | 820K | 1.0 |
| 2025-09-15 | 760K | -6.0% | 1.42% | 4.6M | 1.0 |
| 2025-08-29 | 809K | +0.6% | 1.51% | 489K | 1.7 |
| 2025-08-15 | 804K | -2.3% | 1.50% | 208K | 3.9 |